Call for Proposals

The Life Science industry has been at the forefront of innovation and creativity, always looking for ways to improve patient safety while maintaining the product quality. As life sciences continue making a variety of products from classical tablets to vaccines and all the way toward personalized medicines, the future of the pharmaceutical industry has never looked more promising. We welcome you to participate at the 2023 ISPE Annual Meeting & Expo to learn and share progress, success stories, best practices, and lessons learned. 

The 2023 ISPE Annual Meeting & Expo will focus on aligning the future of pharmaceutical sciences and manufacturing as the industry becomes more global, synchronized, digitalized, and quality driven. This signature event draws pharmaceutical and biopharmaceutical professionals at all levels of the industry from students and emerging leaders to the most senior executives in drug manufacturing, supply chain, devices and equipment and services, and global regulatory agencies.

Submit Proposal


Call for Proposals Timeline

  • Submission Opens
  • Submission Deadline
  • Notifications Sent

Requested Submission Topics 

The pandemic has highlighted the importance of a resilient, agile supply chain, as well as strong collaboration between industry and regulators. Despite these learnings, an aging population and an unprecedented rise in chronic diseases mean that the need for a constant focus on collaborative innovation and agility will shape Pharma’s priorities in the foreseeable future. ISPE will be the leader to set the pace for knowledge sharing that speaks to both current and future needs of the industry 

The 2023 ISPE Annual Meeting & Expo Planning Committee is requesting proposals, with preference given to those aligning with the following themes:

  • Advanced Therapy & Manufacturing

    Advanced manufacturing is a collective term for new medical product manufacturing technologies that can improve drug quality, address shortages of medicines, and speed time-to-market. It refers to different production techniques that integrate novel technological approaches, use established techniques in a new or innovative way, or apply production methods in a new domain where there are no defined best practices or experience. Examples of some cross-cutting advanced manufacturing technologies include personalized medicine and 3D printing.

  • Digital Transformation

    Digitalization and the management of big data plus its analytics enables the control, prediction, and optimization of related biopharmaceutical business management trends and processes. The organizational requirements, cultural change, workforce training and infrastructure required for Digital Transformation are captured in the 4 principles of Pharma 4.0: Resources, Organization, Culture, and Information Systems. A successful Digital Transformation leverages GAMP good practices to ensure the effective implementation and management of the computerized systems supporting the business processes, and to safeguard the integrity of the data being created and on which decisions and improvements will be based.

  • Manufacturing, Quality Control, & Operational Excellence

    Applying harmonized approaches to innovative design solutions and project delivery strategies to ensure that quality therapeutic products are brought to market in an efficient manner to improve patient health. This includes manufacturing and QC process improvement, the business strategies, and technology associated with the future state of industry.

  • Regulatory, Compliance, & Quality

    Regulatory and quality challenges, learnings, and opportunities which might include the current speed to market expectations, regulatory harmonization initiatives (ICMRA / PQKMS initiatives and Q12) and guidance updates, drug shortages, and the regulatory focus on data integrity.

  • Supply Chain Resiliency

    The robustness and adaptive capability of the pharmaceutical manufacturer’s supply chain to prepare for unexpected events, respond to disruptions, and recover from them by maintaining continuity of operations at the desired level of connectedness and control over structure and function.

  • Sustainability

    Use of novel, environmentally cognizant technologies, processes and models such as digital twins, and strategies that reduce waste, energy, and materials consumption, and help pharmaceutical companies to reduce their industry footprint, and become more efficient and sustainable.


Proposal Submissions Types

  • 90-Minute Session

    Full session

    • Proposal to develop and lead a full 90-minute session
    • Include elements of attendee engagement
    • Include proposed topics and speakers/panelists/facilitators
    • Explain what will be unique, innovative, or interactive in your session

    Panel discussion

    • A panel discussion in the style of “Expert Roundtable,” with approximately 5-minute presentations from up to 8 subject matter experts, followed by a moderated and interactive panel discussion.
  • Workshop
    • Proposal to develop and lead a 2-3 hour active, engaging workshop
    • Include group activities, demonstrations, proto-typing, and/or other creative learning elements
    • Include proposed facilitators (other than submitter), credentials, and contact information
    • Include actionable learning objectives for participants
  • Oral Presentation

    Individual, 20-minute presentations

    • These presentations are to be made part of a larger session by the Program Committee
    • Presentation should focus on new and innovative trends, a specific real-world strategy or campaign, a “how-to" presentation intended to help attendees gain a better understanding of the initiative and best practices that they can apply to their day-to-day objectives or overall missions

    Rapid fire session

    • Rapid-fire, Hot Topic Sessions are 30-minute sessions focused on a high-level overview of an emerging trend. These sessions are designed to be both cutting-edge and highly focused, requiring the presenter to share ideas and achieve learning objective(s) in 20 minutes, with the remaining 10 minutes open for interactive discussion. These sessions are intended for one speaker but if the topic warrants, can have a maximum of two (2) speakers.

Proposal Guidelines

  • All presentations must be free of commercial intent. Incomplete proposals will not be considered.
  • Each proposal must address two themes. As an example, when submitting a proposal, if your topic would focus on “Manufacturing, Quality Control, & Operational Excellence” and “Sustainability,” you would choose these two themes. 
  • By submitting a proposal, you acknowledge that, if your proposal is accepted, the speaker will attend/present in-person at the event and the speaker’s attendance at the event will be supported by their organization. 
  • Accepted Annual Meeting speakers are responsible for their own travel and accommodations.
  • Speakers giving at least a 20-minute presentation (not including Q&A) will receive a full registration at a discounted rate. 
  • Co-Speakers, Panelists, and Poster Presenters receive a 20% discount on conference registration.
  • NOTE: Exhibitors who are accepted to present are required to register as a paid conference attendee (with 20% discount off prevailing registration rate).  Complimentary booth staffing registrations cannot be utilized for the presentations as these are part of the education sessions and not the exhibition.
  • Consulting firms or vendor/suppliers are encouraged to include a speaker from an owner company to present. 
  • Regulators interested in submitting a proposal: Please contact Saana Tykka to submit your abstract.